CSIMarket Company Name, Ticker, Suppliers, else..
 
Dss Inc   (NYSEAMER: DSS)
 
Price: $0.8300 $-0.02 -2.353%
Day's High: $0.8504999876022339 Week Perf: 54.56 %
Day's Low: $ 0.68 30 Day Perf: 66 %
Volume (M): 9,451,401 52 Wk High: $ 1.86
Volume (M$): $ 0 52 Wk Avg: $0.88
Open: $0.77 52 Wk Low: $0.36



 Market Capitalization (Millions $) 8
 Shares Outstanding (Millions) 10
 Employees 102
 Revenues (TTM) (Millions $) 18
 Net Income (TTM) (Millions $) -31
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Business Description


DSS Inc is a software development company that specializes in creating innovative solutions for the aerospace, defense, and natural resource industries. With over 30 years of experience, they have built a reputation for delivering high-quality software for complex and mission-critical systems. Their solutions include data analytics, decision support systems, and enterprise software integration. DSS Inc is committed to providing their clients with reliable and efficient software that helps them make better decisions and improve their operational processes.


   Company Address: 275 Wiregrass Pkwy West Henrietta 14586 NY
   Company Phone Number: 325-3610   Stock Exchange / Ticker: NYSEAMER DSS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GPK   -9.78%    
• View Complete Report
   



Announcement

DSS, Inc. Applauds Impact BioMedical Inc.s IPO Triumph A New Era of Shareholder Value and Healthcare Innovation,

Published Mon, Sep 16 2024 8:26 PM UTC

NEW YORK, Sept. 16, 2024 In a significant milestone for both companies and their stakeholders, DSS, Inc. (NYSE American: DSS) has officially announced its delight over the successful initial public offering (IPO) of its dedicated partner and investment, Impact BioMedical Inc. (NYSE American: IBO). The IPO, priced at $3.00 per share, marks a pivotal moment for Impact BioMe...
Product Service News

Impact Biomedical's Laetose Technology Advances with U.S. Patent Allowance for Low Glycemic Sugar Composition

Published Tue, Jan 30 2024 1:06 PM UTC

In a groundbreaking development, Impact Biomedical Inc. (IBIO), a company in which DSS Inc. holds a significant investment, has achieved a major milestone with its proprietary Laetose technology platform. This exciting breakthrough comes in the form of a U.S. Patent Allowance, with the U.S. Patent and Trademark Office (USPTO) recently granting the company patent 11,898,184....
Stock Market Announcement

Chairman's Bold Move: DSS, Inc. Chairman Increases Personal Investment to Fuel Company Growth

Published Thu, Jan 4 2024 1:15 PM UTC



In a recent press release, DSS, Inc. announced that Chairman of the Board, Heng Fai Ambrose Chan, has acquired an impressive 672,173 shares of the company in the open market. This move aims to increase Chan s investment in the company, signaling strong confidence in its future prospects. These developments come at a time when DSS, Inc. has 140,140,913 million share...
Contract

Premier Packaging, a DSS, Inc. Subsidiary, Expands Revenue Potential to Over $15 Million with Major Retailer Contract Extension

Published Tue, Nov 28 2023 1:10 PM UTC

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Lucrative Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
Premier Packaging, a prominent subsidiary of DSS, Inc., has recently announced the successful extension of its contract with a major retailer, guaranteeing potential revenue of over $15 million. This four-year contrac...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.45
Price to Sales (Expected) -
Price to Book 0.99
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.6
Working Capital Ratio 0.92
Leverage Ratio (MRQ) 8.13
Total Debt to Equity 4.4
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.64 $
Revenues (TTM) 1.83 $
Cash Flow (TTM) -
Cash 0.68 $
Book Value 0.84 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 179,853
Net Income per Employee (TTM) -303,667
Receivable Turnover Ratio (TTM) 7.55
Inventory Turnover Ratio (TTM) 4.37
Asset Turnover Ratio (TTM) 0.2

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -105.05 %
Net Margin (MRQ) -139.71 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Dss Inc's Segments
Securities Revenue Information Commission Income    13.18 % of total Revenue
Printed Products    205.47 % of total Revenue
Product Packaging    206.38 % of total Revenue
Member    220.14 % of total Revenue
Printed Products Revenue Information    206.38 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.